IGMS - IGM Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart

IGM Biosciences's activity chart (see below) currently has 136 price targets and 105 ratings on display.

Stock Analyst Price Targets - Review

Analysts' price targets on this stock were met 41.43% of the time, taking 57.2 days on average.

Most recent stock forecast was given by from TRUIST on 11-Jun-2025. First documented stock forecast 13-Oct-2019.

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 10-Jan-2025

$1

$2

1 years 5 months 10 days ago
(11-Jun-2025)

2/8 (25%)

$-0.27 (-21.26%)

99

Hold Since 08-Apr-2025

$0.75

1 years 7 months 13 days ago
(08-Apr-2025)

0/3 (0%)

$-0.27 (-26.47%)

Hold Since 07-Mar-2025

$2.5

$2.5

1 years 8 months 14 days ago
(07-Mar-2025)

2/8 (25%)

$1.18 (89.39%)

42

Sell Since 13-Jan-2025

$9

1 years 10 months 8 days ago
(13-Jan-2025)

3/5 (60%)

$-5.5 (-37.93%)

48

Buy Since 09-Nov-2022

$2

$48

1 years 10 months 11 days ago
(10-Jan-2025)

1/4 (25%)

$-0.09 (-4.31%)

3

Show more analysts

Please expand the browser size to see the chart

What is IGMS (IGM Biosciences) average time for price targets to be met?

On average it took 57 days for the stock forecasts to be reached, with an average price target met ratio of 41.43%.

Which analyst most recently updated their price target on IGMS (IGM Biosciences)?

Which analyst has the most public recommendations on IGMS (IGM Biosciences)?

has 0 price targets and 0 ratings on IGMS

Which analyst is the currently most bullish on IGMS (IGM Biosciences)?

Chris Howerton with the highest potential upside of $124.73

Which analyst is the currently most reserved on IGMS (IGM Biosciences)?

Geoff Meacham with the lowest potential downside of -$0.52
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?